Search

Mirati Therapeutics Inc

Open

SectorGezondheidszorg

0

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

-0.05% downside

Nieuwssentiment

By Acuity

28%

72%

55 / 340 Rangschikking in Healthcare

Mirati Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

20 jul 2026, 23:56 UTC

News

Brookdale Senior Living announced its second-quarter 2026 earnings release dates, boosting investor sentiment. Shares are trading higher in after-market hours.

20 jul 2026, 23:56 UTC

News

Valero Energy Corp gains in after-market trading on strong earnings forecast, with projected EPS of $9.81 and revenue expectations of $35.95 billion.

20 jul 2026, 23:51 UTC

News
Correlated Moves

Ally Financial shares are lower in after-market trading despite the board declaring a quarterly cash dividend of $0.30 per share.

20 jul 2026, 23:51 UTC

Social Media
News

Magnolia Oil & Gas announced a $1 billion stock offering to fund the acquisition of WildFire Intermediate Holdings, resulting in a sharp decline in after-market hours.

20 jul 2026, 23:46 UTC

News

Advanced Energy Industries gained after-market hours following $31 million in funding for the Idaho Advanced Energy Consortium's Nuclear Energy Corridor Tech Hub initiative.

20 jul 2026, 23:46 UTC

News

Ross Stores announced 47 new locations but shares are trading lower in after-market hours following Monday's close. The company plans to open about 110 stores in 2026.

20 jul 2026, 23:46 UTC

News

Monarch Casino & Resort Inc reports record Q2 revenue of $142.6 million and EPS of $1.78, trading higher in after-market hours.

20 jul 2026, 23:46 UTC

News

Sweetgreen Inc shares are higher in after-market trading, despite ongoing concerns in the restaurant sector over a cyclospora outbreak linked to iceberg lettuce.

20 jul 2026, 23:46 UTC

News

Warner Bros Discovery shares are lower in after-market hours as a judge pauses the $110 billion Paramount Skydance acquisition, extending legal uncertainty.

20 jul 2026, 23:41 UTC

News
Event

Calix Inc's stock is lower in after-market trading following a mixed earnings report and a disappointing third-quarter outlook, alongside a class action lawsuit.

20 jul 2026, 23:36 UTC

News

GameStop shares are lower in after-market hours as the company proposes a stock-based acquisition of eBay, introducing significant new debt and operational changes.

20 jul 2026, 23:36 UTC

News
Correlated Moves

Invesco Ltd's shares rose during after-market hours, reflecting a modest increase since Monday's close, alongside gains in the Invesco S&P 500 High Dividend Low Volatility ETF.

20 jul 2026, 23:36 UTC

News

Jazz Pharmaceuticals PLC will report second-quarter results on August 3, contributing to positive investor sentiment as shares trade higher after market hours.

20 jul 2026, 23:32 UTC

News

Broadcom Inc. shares are higher in after-hours trading, driven by strong historical returns and potential growth from Meta Platforms' AI chip production plans.

20 jul 2026, 23:26 UTC

News
Correlated Moves

Blackstone Inc. shares are higher in after-market trading following a $676 million investment in South Korea's Futronic, enhancing its technology portfolio.

20 jul 2026, 23:16 UTC

News

Enphase Energy shares fell after TD Cowen cut its price target from $70 to $48, citing a challenging solar market and weaker demand. The stock was roughly flat in after-market trading.

20 jul 2026, 23:16 UTC

News
Social Media

Alphabet Inc shares are higher in after-market hours as reports reveal plans for a new AI chip that may significantly outperform current models.

20 jul 2026, 23:16 UTC

News

Quanta Services reported a $48 billion backlog, signaling strong revenue potential. Shares moved higher in after-market hours amid bullish analyst sentiment.

20 jul 2026, 23:06 UTC

News

ServiceNow Inc. shares are trading lower in after-market hours amid bearish sentiment over potential disruptions from generative AI and rising Treasury yields.

20 jul 2026, 23:06 UTC

News

Pomerantz LLP has filed a class action lawsuit against Lucid Group Inc, alleging securities fraud related to misleading statements about operational capabilities and performance.

20 jul 2026, 23:06 UTC

News
Social Media

General Electric Co advances in aviation technology with a hybrid-electric flight demonstration and secures an engine deal with Philippine Airlines, shares higher after-market.

20 jul 2026, 23:06 UTC

News

Geopolitical tensions, particularly between the U.S. and Iran, have impacted global consumer sentiment. Nike shares were little changed during after-market hours.

20 jul 2026, 23:06 UTC

News

Yum Brands Inc shares declined after a report of reduced foot traffic at Taco Bell due to a parasite outbreak linked to lettuce supplied by a vendor.

20 jul 2026, 23:02 UTC

News

Zions Bancorporation NA reported Q2 earnings of $452 million, or $3.05 per share, but shares are lower in after-market trading amid mixed results.

20 jul 2026, 23:02 UTC

News

W. R. Berkley Corporation reported strong second-quarter earnings but missed revenue expectations. Shares declined during after-market hours amid notable volatility.

20 jul 2026, 23:01 UTC

News

Coca-Cola Consolidated Inc shares rose during after-market hours, reflecting positive sentiment in the beverage sector despite earlier session volatility.

20 jul 2026, 23:01 UTC

News

Karyopharm Therapeutics shares fell in after-market hours following the announcement of a leadership cash retention program aimed at key executives.

20 jul 2026, 23:01 UTC

Social Media
News

Park Aerospace Corp reported first-quarter earnings of $0.17 per share, exceeding estimates, and is trading higher in after-market hours.

20 jul 2026, 23:01 UTC

News
Event

Cracker Barrel completed a sale-leaseback for 26 locations, generating $77 million. Shares are trading higher after exceeding previous revenue guidance.

20 jul 2026, 23:01 UTC

News
Social Media
Event

Crown Holdings reported second-quarter adjusted EPS of $2.49, exceeding estimates. The company raised its full-year EPS guidance, with shares higher in after-market hours.

Peer Vergelijking

Prijswijziging

Mirati Therapeutics Inc Prognose

Koersdoel

By TipRanks

-0.05% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 58.67 USD  -0.05%

Hoogste 59 USD

Laagste 58 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Mirati Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

5 ratings

0

Buy

5

Hold

0

Sell

Sentiment

By Acuity

55 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

EBITDA

Operationele winst

$

Over Mirati Therapeutics Inc

Mirati Therapeutics, Inc. is a clinical-stage oncology company. It is focused on developing therapeutics to address the genetic and immunological promoters of cancer. Its clinical programs consist of product candidates, including Adagrasib (MRTX849), MRTX1133, and Sitravatinib. MRTX849 is an oral small-molecule therapy designed to shrink difficult-to-treat cancers harboring the KRAS G12C mutation. MRTX1133 is a small molecule-inhibitor of the KRASG12D mutation, designed to treat patients with unmet need. Sitravatinib is a spectrum-selective receptor tyrosine kinase (RTK) inhibitor that can stimulate the body’s immune response to fight cancer. MRTX849 is in Phase III and Phase I/II clinical trials and MRTX1133 is in preclinical development. Sitravatinib is in a Phase III clinical trial, and Phase I/II clinical trials. It also has additional preclinical discovery programs, which includes first-in-class and best-in-class product candidates designed to address mutations and tumors.
help-icon Live chat